About: Can biological markers improve the management of breast cancer patients? Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Can biological markers improve the management of breast cancer patients? Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2000 (uk) im Mai 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2000 (ast) scientific article published on 01 May 2000 (en) գիտական հոդված հրատարակված 2000 թվականի մայիսի 1-ին (hy)
publication date	wds:Q73806668-39528A75-940B-49D3-8CAE-42F67E81ED00
publication date	2000-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73806668-092F5B0A-FBB5-4757-8277-F605A81F5D9E
language of work or name	English
exact match	wds:Q73806668-5804AFDD-7B2E-4D73-B36C-08F25FAB16D9
exact match	https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1159
cites work	wds:Q73806668-03D89A26-CE61-4999-95B2-DF38DBC4AD3D wds:Q73806668-5374E87D-81C6-4661-A60E-9FACDEFC9454 wds:Q73806668-82327D38-B8CD-47D5-B569-D419021C64A7 wds:Q73806668-AD75C0FB-CFAE-40AD-A7DF-DAE6CE54BEA7 wds:Q73806668-E0D5F000-D9BE-43BC-8158-A8567882EA91 wds:Q73806668-F5CB7578-7697-4C0A-8C3F-E58BE84D6765 wds:Q73806668-F833F88D-8B90-447A-9814-7AF0A2743BE4
cites work	Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy Oestrogen-receptor status in management of breast cancer in UK c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group Oestrogen receptors and breast cancer Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance
rdfs:label	Can biological markers improve the management of breast cancer patients? Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research (en) Can biological markers improve the management of breast cancer patients? Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research (nl)
skos:prefLabel	Can biological markers improve the management of breast cancer patients? Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research (en) Can biological markers improve the management of breast cancer patients? Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research (nl)
name	Can biological markers improve the management of breast cancer patients? Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research (en) Can biological markers improve the management of breast cancer patients? Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research (nl)
title	wds:Q73806668-79923106-A343-4AFE-B01F-7FED598D542F
title	Can biological markers improve the management of breast cancer patients? Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research (en)
page(s)	wds:Q73806668-4D1740F0-6C45-4A94-8939-D0E702A05050
page(s)	1625-1626
instance of	wds:Q73806668-B0FCC250-03FB-453B-AC96-A51DE1995DC6
instance of	scholarly article
main subject	wds:Q73806668-39D1FA97-B6BF-4DCA-8B46-1AAFC6456E28 wds:Q73806668-655B4BD8-E823-495D-9A99-923AE0A7BBFF
main subject	United Kingdom biomarker
PubMed ID	wds:Q73806668-74149B0D-790E-44A2-9CEC-FAAA6656EA28
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10817494
PubMed ID	10817494
published in	wds:Q73806668-B40F7665-8B4C-4072-B4E4-B5AC9E3F6D61
published in	British Journal of Cancer
issue	wds:Q73806668-94BA7B42-BE4E-4A84-B7A2-BA251D3FC5CC
volume	wds:Q73806668-5D73450F-9A48-4284-8968-12E3149CE402
issue	10
volume	82
DOI	wds:Q73806668-674B6653-398E-44FC-A2CB-BA35D04FD5EE
DOI	http://dx.doi.org/10.1054/BJOC.2000.1159
DOI	10.1054/BJOC.2000.1159
Dimensions Publication ID	wds:Q73806668-2ED9109B-48DE-46B8-90D9-FF2B52BAC35E
Dimensions Publication ID	1025868899
PMCID	wds:Q73806668-C3E12741-FF16-4036-A107-2075D51A6D09
PMCID	2374516
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73806668
is cites work of	Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma
is cites work of	wds:Q38453317-C0001203-0C3E-451A-A970-4736EAFDF5E0

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software